...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: 2023 Outlook per MD&A
7
Apr 06, 2023 05:02PM
1
Apr 06, 2023 08:06PM

Investalot

I got in this right before the assure trial failure in 2013 at about $3 and then built a nice position for the BOM trial failure. Will this ever see $20 again? By the looks of the MD&A they are still beating the drums. Covid and BOM2 trials planned to kick off in 2023 and double the trial participants - all with non-dilutive financing. Who knows? Looks like another 2 or 3 years before RVX sees an interim result. Possibly late 2024 results for a Covid trial.

Chicagoest

3
Apr 07, 2023 11:46AM
5
Apr 07, 2023 03:05PM
3
Apr 08, 2023 10:50PM
1
Apr 08, 2023 10:57PM
2
Apr 09, 2023 07:20AM
4
Apr 09, 2023 07:56AM
3
Apr 09, 2023 01:24PM
Share
New Message
Please login to post a reply